The Annual Transfusion Medicine Update Conference offers valuable opportunities for professionals in the field of transfusion medicine to stay updated on the latest research, share insights and network with peers globally.

This gathering brings together leading experts, healthcare professionals, researchers, and industry pioneers to explore the latest advancements, challenges, and innovations in transfusion medicine. As we embark on this journey of learning and collaboration, we look forward to insightful discussions, groundbreaking research presentations and the opportunity to share best practices that will shape the future of patient care. Whether you are here to present, learn, or network, we encourage you to engage fully and make the most of this unique experience.
This is an excellent opportunity to share your research, case studies and innovative practices with fellow experts in transfusion medicine, hematology, and patient care.

Abstract submission deadline: Monday, 1 September, 2025 – 11:59 PM (GST).
Notification on Acceptance/Rejection: Tuesday, 30 September 2025 – 11:59 PM (GST).

To submit an abstract, please read all of the instructions below:

Submissions will be made within 2 categories:

• Oral Presentation
• Poster Presentation

Topics Accepted

• Blood Component Processing and Storage
• Transfusion Medicine Practice
• Patient Blood Management
• Transfusion Safety and Hemovigilance
• Blood Donor Management
• Laboratory Methods in Transfusion Medicine
• Emerging Technologies in Blood Banking
• Quality Management in Blood Banks
• Donor and Therapeutic Apheresis
• Regional Transfusion Medicine Challenges
• Cell therapies

Language
Abstract must be submitted in English using the online submission form on the Annual Transfusion conference website.

General conditions

1. Please note that only electronic submissions through the abstract submission website are accepted.
2. Abstract must be submitted by Monday, 1 September, 2025 – 11:59 PM (GST). Abstract received after this time will not be accepted for judging.
3. Abstract must be submitted in English.
4. Withdrawal of abstract can only be accepted if notified in writing. It is possible to withdraw an abstract 7 days after notification on acceptance.
5. If selected, it is the responsibility of the presenter to bear registration, travel and accommodation expenses.
6. All correspondence relating to scientific abstract will be undertaken by email with the first named author.
7. Entrants will be advised no later than Tuesday, 30 September 2025 – 11:59 PM (GST), on the acceptance of rejection of their abstract.

Presenting Author and Registration

1. Please verify that your email address (submitter and presenting author) is correct as it will be used for contacting you after the review process.
2. Disclosure: Abstract submitter and presenter are required to disclose any conflict of interest.
3. Ensure that all co-authors approve the abstract submission, publication and potential presentation.
4. At least one of the named authors or all co-authors of an abstract must be a registered paying delegate for the conference they are submitting their abstract for, to be able to present the abstract. Registrations must be received by Wednesday, 15 October 2025.
5. Scientific committee reserves the right to exclude any abstract that is not followed by a participant registration at the latest 7 days after notification on acceptance.

Contents of your abstract

1. Title: Maximum 200 characters (no commercial product names)
2. Length: Maximum 3500 characters (including spaces)
3. Structure must include:
   ✓ Background
      ✓ Aims
      ✓ Method
      ✓ Result
      ✓ Summary/Conclusion
4. Language: English
5. Tables: Maximum one table permitted
6. Graphics/Images: Not permitted
7. Abstract uploaded should only be submitted in the Microsoft Word format, single-spaced, using size 12 Times New Roman font.
8. Abstract should highlight major points of your research and explain why your work is important; what your purpose was, what you learned, and what you concluded.
9. The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract title in CAPITAL LETTERS. No full stop at the end. The title of the abstract during the Poster or Oral presentation at the conference should be the same as the title on the submitted abstract.
10. All abbreviations must be defined in first use.
11. No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of author(s) and their institution(s), when you submit the abstract online.
12. Statements such as “results will be discussed” or “data will be presented” cannot be accepted.
13. By submitting an abstract, the authors confirm that the abstract is their own original work, is not defamatory or unlawful and does not infringe anyone else’s rights.
14. Submission of material which has previously been submitted and or presented elsewhere is welcomed providing copyright is not infringed
15. No amendments or additions to abstract or authors can be made once your abstract has been submitted. Please ensure that all information is correct and all authors are listed when submitting
16. Please note that all submissions are subject to proof reading and editing

Decisions

1. Judges appointed by the Scientific Committee will assess and judge scientific abstract for both e-poster and oral presentations.
2. To avoid any conflict of interest, a “blind” review process will be used.
3. The decision of the judges is final.

Coming Soon